Synthesis and radioiodination of 7-(3′-ammoniopropyl)-7,8-dicarba-nido-undecaborate(-1), (ANC)

Derivatives of nido‐carborate have potential use in tumour targeting as hydrophilic boron‐rich compounds for boron neutron capture therapy (BNCT) and as pendant groups for attachment of radiohalogens to tumour‐seeking molecules. For this purpose, functionalized derivatives of nido‐carborates that ca...

Full description

Saved in:
Bibliographic Details
Published inJournal of labelled compounds & radiopharmaceuticals Vol. 47; no. 9; pp. 557 - 569
Main Authors Ghirmai, Senait, Malmquist, Jonas, Lundquist, Hans, Tolmachev, Vladimir, Sjöberg, Stefan
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.08.2004
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Derivatives of nido‐carborate have potential use in tumour targeting as hydrophilic boron‐rich compounds for boron neutron capture therapy (BNCT) and as pendant groups for attachment of radiohalogens to tumour‐seeking molecules. For this purpose, functionalized derivatives of nido‐carborates that can be conjugated to biomolecules should be synthesized and evaluated. In this study, racemic 1, 7‐(3′‐ammoniopropyl)‐7,8‐dicarba‐nido‐undecaborate(‐1) (acronym ANC) was obtained by degradation of the corresponding aminopropyl‐o‐carborane, which was synthesized in three steps from 1‐tert‐butyldimethylsilyl‐2‐(3‐bromopropyl)‐o‐carborane, with sodium hydroxide in absolute ethanol. The racemate 1 was radioiodinated (125I) using the Chloramine‐T method. Radio‐TLC results showed that radiolabelling with 125I was achieved in a yield greater than 95%. Copyright © 2004 John Wiley & Sons, Ltd.
Bibliography:Swedish Cancer Society - No. 4462-B01-02PAA
Carl Trygger Foundation for Scientific Research
ArticleID:JLCR840
istex:6E7949265B881A6D7924D2F4E2AFC3473DB22171
ark:/67375/WNG-C4SP3LVV-X
INTAS - No. 99-00806
Swedish Cancer Society - No. 3009-B02-13XAC
ISSN:0362-4803
1099-1344
1099-1344
DOI:10.1002/jlcr.840